PCNA and neoplasm: In addition, IHC staining indicated the Ki67 and PCNA expression levels were significantly lower in the combination treatment group, which confirmed the powerful anti-tumor effect of imperatorin plus gemcitabine regimen in PDAC (Fig. 8f–i).